Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Abe, K
Right arrow Articles by Watanabe, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abe, K
Right arrow Articles by Watanabe, T
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology Pages 399-402

Meeting Report
Introduction
Session 1: Epidemiology and risk factor
Session 2: Prevention, basic and clinical approach
Session 3: Screening program
Session 4: Familial breast cancer and gene counseling
Session 5: Pathology
Session 6: Prognostic factors
Session 7: Imaging diagnostics and sentinel node biopsy
Session 8: Surgery and post-surgical follow-up
Session 9: Chemotherapy tailored for individual patients and high dose chemotherapy
Session 10: Hormone receptor function and endocrine therapy
Session 11: Bone metastasis
Session 12: New treatments based on biology
Session 13: Summary of the Symposium
Acknowledgements
Report of the Twelfth International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Breast Cancer

Report of the Twelfth International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Breast Cancer

Kaoru Abe1 and Toru Watanabe2

1President Emeritus and 2Department of Medical Oncology, National Cancer Center, Tokyo, Japan

INTRODUCTION

The 12th International Symposium of the Foundation for Promotion of Cancer Research, entitled `Basic and Clinical Research in Breast Cancer' was held . . . [Full Text of this Article]

SESSION 1: EPIDEMIOLOGY AND RISK FACTOR

SESSION 2: PREVENTION, BASIC AND CLINICAL APPROACH

SESSION 3: SCREENING PROGRAM

SESSION 4: FAMILIAL BREAST CANCER AND GENE COUNSELING

SESSION 5: PATHOLOGY

SESSION 6: PROGNOSTIC FACTORS

SESSION 7: IMAGING DIAGNOSTICS AND SENTINEL NODE BIOPSY

SESSION 8: SURGERY AND POST-SURGICAL FOLLOW-UP

SESSION 9: CHEMOTHERAPY TAILORED FOR INDIVIDUAL PATIENTS AND HIGH DOSE CHEMOTHERAPY

SESSION 10: HORMONE RECEPTOR FUNCTION AND ENDOCRINE THERAPY

SESSION 11: BONE METASTASIS

SESSION 12: NEW TREATMENTS BASED ON BIOLOGY

SESSION 13: SUMMARY OF THE SYMPOSIUM

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
P. S. Multani, K. Tobinai, T. Kakizoe, J. O. Armitage, R. Ohno, and T. Sugimura
Report of the Fifteenth International Symposium of the Foundation for Promotion of Cancer Research: New Horizons in the Diagnosis and Treatment of Hematological Malignancies Based on Molecular Genetic Features
Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 371 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
J. Collins, N. Shimoyama, E. Bruera, F. Takeda, T. Kakizoe, and T. Sugimura
Report of the Fourteenth International Symposium of the Foundation for Promotion of Cancer Research: Pain Control, Palliative Medicine and Psycho-oncology
Jpn. J. Clin. Oncol., September 1, 2001; 31(9): 459 - 468.
[Full Text] [PDF]